News

Research, Prevention and Control of Influenza

Influenza Centre’s research in NRK

Nina Urke Ertesvåg, PhD student at the Influenza Centre, presented results of her research on the recognition of different influenza viruses by the immune system in NRK. The findings showed that people who have received several vaccines more often recognize viruses from several strains. – We have proven that the influenza vaccine works more broadly…
Read more

Publication of a new manuscript

The manuscript on ‘Vaccination rates in Europe are not associated with online media intensity’, written by VACCELERATE consortium has been published open access in the Journal of Science Communication. One of the co-authors of the manuscript is Professor Rebecca Cox, Head of the Influenza Centre. You can find the full publication here: https://doi.org/10.22323/2.21050205, and read…
Read more

Research on long COVID presented in TV2

In an interview for the Norwegian TV2, Nina Langeland and Rebecca Cox explained the results of a new study conducted by the University of Bergen and Haukeland University Hospital on long COVID. – As many as 46 percent of the COVID patients in our study report long-term effects, and that is high, said Nina Langeland,…
Read more

Case report on a SARS-CoV-2 infected immunocompromised patient

We have published a case report about an immunocompromised patient (treated with Rituximab against multiple sclerosis) with longterm fever, hypoxia and low-grade SARS-CoV-2 infection. The patient was hospitalized three times over a period of 102 days.  The case report describes the clinical and diagnostic challenges and the interdisciplinary team work needed to distinguish hyperinflammation from…
Read more

New article on long-term symptoms among people with a mild to moderate course of acute COVID-19

Although most people who undergo SARS-CoV-2 infection recover, a significant proportion suffer long-term symptoms and late sequelae, also known as long COVID. We investigated long COVID symptoms in 233 people with a mild to moderate course of acute COVID-19. Our study showed that 46% of COVID-19 infected participants had one or more long COVID symptoms…
Read more

VACCELERATE’s educational video for children

An educational video for kids from the VACCELERATE project about the importance and value of clinical trials is now available in several languages (English, German, Greek and Spanish). Listen to what the fairy “Well-being” has to say: https://youtube.com/watch?v=YZqPSe-YyxY  

VACCELERATE newsletter

The VACCELERATE clinical research network that the Influenza Centre is engaged in has issued its first newsletter. You can access the full version on the VACCELERATE website: https://vaccelerate.eu/newsletters/ Check it out!

Sarah’s completed PhD

Our colleague Sarah Larteley Lartey Jalloh successfully defended her PhD thesis entitled “Humoral and cellular immune responses after pandemic and seasonal influenza vaccination in humans” on June 22, 2022. Her work was supervised by the Head of the Influenza Centre – Professor Rebecca Cox, and co-supervisors – Åsne Jul-Larsen and Fan Zhou. Sarah’s trial lecture…
Read more

Looking for 50 Bergen inhabitants over 75 who will get the 4th dose of COVID-19 vaccine

50 people from Bergen who are 75 years old or older will receive the fourth dose of the mRNA vaccine against COVID-19, as part of the EU-COVAT AGED study connected to the VACCELERATE project aiming to investigate how the immune system responds to one more booster dose of the vaccine. 20 patients have already been…
Read more

Sarah Larteley Lartey Jalloh PhD thesis defence

Sarah Larteley Lartey Jalloh who is a member of our Influenza group will defend her PhD thesis on “Humoral and cellular immune responses after pandemic and seasonal influenza vaccination in humans” on June 22, 2022. Her opponents will be Professor Hideki Ueno (Kyoto University, Japan) and Researcher Ranveig Braathen (University of Oslo, Norway), with Associate…
Read more

en_USEnglish